Peer Partners to Improve Physical Activity in Older Latino and Latina Adults With Parkinson's Disease.

NCT06170866 | Completed Results

• 2 other identifiers: 23-117S-2P30AG067988
• Study Type: interventional
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this interventional study is to culturally adapt and determine feasibility of the peer partner training program and the peer-supported mobile health physical activity intervention in older Latin/Hispanic people with Parkinson's disease. The main question\[s\] it aims to answer are:

• What is the feasibility of the peer partner training program?
• What is the feasibility of the peer-supported mobile health physical activity intervention?
• What are the effects of the peer-supported mobile health physical activity intervention on physical activity, motivation, depression, apathy and self-efficacy? Participants will be asked to:
• Wear a research-grade activity monitor, Actigraph GT9X device for 10 days at the beginning and end of the study.
• Watch 11 educational videos about Parkinson´s disease and exercise and attend two virtual educational sessions.
• Connect with another person with Parkinson´s disease one time a week on a virtual meeting platform for 8 weeks.
• Use Fitbit activity monitors and connect with other participants through the Fitbit application for 8 weeks.
• Attend a weekly online exercise class for 8 weeks with other people with Parkinon´s disease.

Conditions

Parkinson Disease

Keywords

Exercise; Peer Support; Hispanic; Parkinson´s Disease

Outcome Measures

Primary Outcomes (3)

• Acceptability of Intervention Measure (AIM)

  A standardized measure of acceptability that indicates percent agreement with acceptability of the intervention ranging from 20-100%. Higher scores indicate agreement (better outcome) with the acceptability of the intervention.

  After completion of the entire intervention (11 weeks)

• Intervention Appropriateness Measure (IAM)

  A standardized measure of appropriateness that indicates percent agreement with appropriateness of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the appropriateness of the intervention.

  After completion of the entire intervention (11 weeks)

• Feasibility of Intervention Measure (FIM)

  A standardized measure of feasibility that indicates percent agreement with feasibility of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the feasibility of the intervention.

  After completion of the entire intervention (11 weeks)

Secondary Outcomes (4)

• Objective Measurement of Physical Activity

  10 days at baseline and post-intervention (approximately 12 to 14 weeks)

• Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)

  Baseline and post Intervention (approximately 12 to 14 weeks)

• Parkinson's Disease Questionnaire-39 (PDQ-39)

  Pre and post intervention (approximately 12 to 14 weeks)

• Geriatric Depression Scale-Short Form

  Pre and post intervention (approximately 12 to 14 weeks)

Study Arms (1)

Social support for physical activity

EXPERIMENTAL

Socially supported (peer, family and group) physical activity group.

Behavioral: Socially supported physical activity

Interventions

Socially supported physical activity BEHAVIORAL

Use of a culturally and linguistically tailored intervention that uses mobile health technology plus social support to increase engagement in physical activity in the management of Parkinson´s disease.

Social support for physical activity

Eligibility Criteria

• Age: 50 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Idiopathic Parkinson disease,
• Able to walk without the assistance of another person for 10 minutes
• ≥ 29 on Telephone Interview for Cognitive Status (TICS)
• To have a close friend/family member over the age of 18 that would support the participant during the intervention
• ≥ 50 years of age
• Hispanic
• To be willing to use an activity monitor and use a Fitbit and Fitbit application
• To be on a stable course of PD medications without any plans for change over the next 3 months
• To be able to speak, read and write in Spanish or English

You may not qualify if:

• Unstable cardiopulmonary, orthopedic, psychological or metabolic condition
• Atypical Parkinsonism Disorders
• A fall in the last 6 months (that was unrelated to an external force)
• Currently engaging in 150 minutes of mod-vigorous physical activity/week

Sponsors & Collaborators

• UConn Health: lead
• National Institutes of Health (NIH): collaborator
• National Institute on Aging (NIA): collaborator

Study Sites (1)

University of Connecticut

Storrs, Connecticut, 06269, United States

Location

Related Publications (32)

• Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT Jr; American Academy of Neurology Parkinson Disease Measure Development Panel. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2010 Nov 30;75(22):2021-7. doi: 10.1212/WNL.0b013e3181ff96dd.

  PMID: 21115958 BACKGROUND

• Rogers G, Davies D, Pink J, Cooper P. Parkinson's disease: summary of updated NICE guidance. BMJ. 2017 Jul 27;358:j1951. doi: 10.1136/bmj.j1951. No abstract available.

  PMID: 28751362 BACKGROUND

• Alberts JL, Rosenfeldt AB. The Universal Prescription for Parkinson's Disease: Exercise. J Parkinsons Dis. 2020;10(s1):S21-S27. doi: 10.3233/JPD-202100.

  PMID: 32925109 BACKGROUND

• Johansson ME, Cameron IGM, Van der Kolk NM, de Vries NM, Klimars E, Toni I, Bloem BR, Helmich RC. Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial. Ann Neurol. 2022 Feb;91(2):203-216. doi: 10.1002/ana.26291. Epub 2022 Jan 19.

  PMID: 34951063 BACKGROUND

• Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, Melanson EL, Jain S, Robichaud JA, Poon C, Corcos DM. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018 Feb 1;75(2):219-226. doi: 10.1001/jamaneurol.2017.3517.

  PMID: 29228079 BACKGROUND

• Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson's Foundation P4 Group. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.

  PMID: 30003140 BACKGROUND

• Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 1;157(11):1015-22. doi: 10.1093/aje/kwg068.

  PMID: 12777365 BACKGROUND

• Damron L, Litvan I, Bayram E, Berk S, Siddiqi B, Shill H. Hispanic Perspectives on Parkinson's Disease Care and Research Participation. J Alzheimers Dis. 2021;81(2):809-819. doi: 10.3233/JAD-210231.

  PMID: 33843687 BACKGROUND

• Fullard ME, Thibault DP, Hill A, Fox J, Bhatti DE, Burack MA, Dahodwala N, Haberfeld E, Kern DS, Klepitskava OS, Urrea-Mendoza E, Myers P, Nutt J, Rafferty MR, Schwalb JM, Shulman LM, Willis AW; Parkinson Study Group Healthcare Outcomes and Disparities Working Group. Utilization of rehabilitation therapy services in Parkinson disease in the United States. Neurology. 2017 Sep 12;89(11):1162-1169. doi: 10.1212/WNL.0000000000004355. Epub 2017 Aug 23.

  PMID: 28835397 BACKGROUND

• Crespo CJ, Smit E, Andersen RE, Carter-Pokras O, Ainsworth BE. Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Prev Med. 2000 Jan;18(1):46-53. doi: 10.1016/s0749-3797(99)00105-1.

  PMID: 10808982 BACKGROUND

• Mantri S, Fullard M, Gray SL, Weintraub D, Hubbard RA, Hennessy S, Willis AW. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease. JAMA Neurol. 2019 Jan 1;76(1):41-49. doi: 10.1001/jamaneurol.2018.2820.

  PMID: 30285047 BACKGROUND

• Hooker SP, Wilcox S, Rheaume CE, Burroughs EL, Friedman DB. Factors related to physical activity and recommended intervention strategies as told by midlife and older African American men. Ethn Dis. 2011 Summer;21(3):261-7.

  PMID: 21942156 BACKGROUND

• Griffith DM, Bergner EM, Cornish EK, McQueen CM. Physical Activity Interventions With African American or Latino Men: A Systematic Review. Am J Mens Health. 2018 Jul;12(4):1102-1117. doi: 10.1177/1557988318763647. Epub 2018 Mar 20.

  PMID: 29557237 BACKGROUND

• Callahan LF, Rivadeneira A, Altpeter M, Vilen L, Cleveland RJ, Sepulveda VE, Hackney B, Reuland DS, Rojas C. Evaluation of the Arthritis Foundation's Camine Con Gusto Program for Hispanic Adults With Arthritis. Hisp Health Care Int. 2016 Sep;14(3):132-40. doi: 10.1177/1540415316665202. Epub 2016 Aug 23.

  PMID: 27553228 BACKGROUND

• Ige-Elegbede J, Pilkington P, Gray S, Powell J. Barriers and facilitators of physical activity among adults and older adults from Black and Minority Ethnic groups in the UK: A systematic review of qualitative studies. Prev Med Rep. 2019 Jul 13;15:100952. doi: 10.1016/j.pmedr.2019.100952. eCollection 2019 Sep.

  PMID: 31367514 BACKGROUND

• Barcelona de Mendoza V, Damio G. Evaluation of a culturally appropriate peer coaching program for smoking cessation. Public Health Nurs. 2018 Nov;35(6):541-550. doi: 10.1111/phn.12542. Epub 2018 Sep 14.

  PMID: 30596399 BACKGROUND

• Colon-Semenza C, Latham NK, Quintiliani LM, Ellis TD. Peer Coaching Through mHealth Targeting Physical Activity in People With Parkinson Disease: Feasibility Study. JMIR Mhealth Uhealth. 2018 Feb 15;6(2):e42. doi: 10.2196/mhealth.8074.

  PMID: 29449201 BACKGROUND

• Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30;68(5):384-6. doi: 10.1212/01.wnl.0000247740.47667.03. Epub 2006 Nov 2.

  PMID: 17082464 BACKGROUND

• Lima LO, Rodrigues-de-Paula F. Recruitment rate, feasibility and safety of power training in individuals with Parkinson's disease: a proof-of-concept study. Braz J Phys Ther. 2013 Jan-Feb;17(1):49-56. doi: 10.1590/s1413-35552012005000069. English, Portuguese.

  PMID: 23538458 BACKGROUND

• Ellis T, Latham NK, DeAngelis TR, Thomas CA, Saint-Hilaire M, Bickmore TW. Feasibility of a virtual exercise coach to promote walking in community-dwelling persons with Parkinson disease. Am J Phys Med Rehabil. 2013 Jun;92(6):472-81; quiz 482-5. doi: 10.1097/PHM.0b013e31828cd466.

  PMID: 23552335 BACKGROUND

• Carvas Junior N, Gomes IC, Valassi JMR, Anunciacao L, Freitas-Dias R, Koike MK. Comparison of the printed and online administration of the Behavioral Regulation in Exercise Questionnaire (BREQ-2). Einstein (Sao Paulo). 2021 Aug 2;19:eAO6088. doi: 10.31744/einstein_journal/2021AO6088. eCollection 2021.

  PMID: 34346988 BACKGROUND

• Bushnell DM, Martin ML. Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res. 1999 Jun;8(4):345-50. doi: 10.1023/a:1008979705027.

  PMID: 10472167 BACKGROUND

• Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.

  PMID: 28851459 BACKGROUND

• Mendoza-Vasconez AS, Marquez B, Benitez TJ, Marcus BH. Psychometrics of the self-efficacy for physical activity scale among a Latina women sample. BMC Public Health. 2018 Sep 5;18(1):1097. doi: 10.1186/s12889-018-5998-0.

  PMID: 30185171 BACKGROUND

• Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999 Jul;52(7):643-51. doi: 10.1016/s0895-4356(99)00049-9.

  PMID: 10391658 BACKGROUND

• Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983;17(1):37-49. doi: 10.1016/0022-3956(82)90033-4.

  PMID: 7183759 BACKGROUND

• Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N. Validating screening tools for depression in Parkinson's disease. Mov Disord. 2018 Jul;33(7):1184-1186. doi: 10.1002/mds.27371. Epub 2018 Mar 24. No abstract available.

  PMID: 29573354 BACKGROUND

• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

  PMID: 11556941 BACKGROUND

• Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006 May;77(5):579-84. doi: 10.1136/jnnp.2005.075929.

  PMID: 16614016 BACKGROUND

• Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30;23(14):2004-14. doi: 10.1002/mds.22229.

  PMID: 18709683 BACKGROUND

• Sallis JF, Grossman RM, Pinski RB, Patterson TL, Nader PR. The development of scales to measure social support for diet and exercise behaviors. Prev Med. 1987 Nov;16(6):825-36. doi: 10.1016/0091-7435(87)90022-3.

  PMID: 3432232 BACKGROUND

• Noroozi A, Ghofranipour F, Heydarnia AR, Nabipour I, Shokravi FA. Validity and reliability of the social support scale for exercise behavior in diabetic women. Asia Pac J Public Health. 2011 Sep;23(5):730-41. doi: 10.1177/1010539509357342. Epub 2010 May 10.

  PMID: 20460282 BACKGROUND

MeSH Terms

Conditions

Parkinson Disease; Motor Activity

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Behavior

Results Point of Contact

• Title: Dr. Cristina Colon-Semenza, Assistant Professor
• Organization: University of Connecticut

cristina.colon-semenza@uconn.edu

8604860019

Study Officials

• Cristina Colón-Semenza, PhD

  University of Connecticut

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Model Details: This is a prospective feasibility trial, single group pre-posttest design and it aims to enroll 20 participants. For this feasibility study, the sample size is comparable to other feasibility trials in populations of individuals with Parkinson disease (Lima \& Rodrigues-de-Paula, 2013; Ellis et al., 2013, Colón-Semenza et al., 2018)17,19,20. This sample size will allow for a comparison in feasibility, acceptability, and appropriateness within and across groups. This sample will allow for identifying trends and preliminary efficacy for this intervention. This study will help to inform an appropriate sample size to adequately power larger samples in future studies

Study Record Dates

• First Submitted: November 10, 2023
• First Posted: December 14, 2023
• Study Start: June 1, 2023
• Primary Completion: July 1, 2024
• Study Completion: August 30, 2024
• Last Updated: November 26, 2025
• Results First Posted: November 26, 2025

Record last verified: 2025-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)